moxifloxacin

Moxifloxacin (Avelox) is a fourth-generation fluoroquinolone that has been shown to be effective against Gram-positive, Gram-negative, and atypical strains, as well as multi-drug resistant Streptococcus pneumoniae.

Decarboxy Moxifloxacin is a decarboxylated compound of moxifloxacin. Moxifloxacin is an oral active 8-methoxyquinolone antibiotic used in acute bacterial sinusitis, chronic bronchitis, acute bacterial deterioration, and community-acquired pneumonia.

Moxifloxacin hydrochloride (BAY12-8039 HCl) is a fourth generation fluoroquinolone with expanded activity against gram-positive bacteria as well as atypical pathogens. Moxifloxacin has been linked to mild ALT elevations during therapy and to rare instances of idiosyncratic acute liver injury with symptoms and jaundice.

Moxifloxacin-D is the hydrochloride salt form of deuterium-labeled Moxifloxacin (Moxifloxacin). This compound acts as an orally effective antibacterial agent and is utilized in research concerning acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and infectious pneumonia.

Moxifloxacinprodrug-1 TFA (Compound 1e) is a prodrug of Moxifloxacin and functions as an antibacterial agent. It exhibits potent activity against Escherichia coli, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa, comparable to Moxifloxacin. Additionally, Moxifloxacin prodrug-1 TFA is capable of inhibiting Mycobacterium tuberculosis.

Moxifloxacin, Hydrochloride Monohydrate is a useful organic compound for research related to life sciences. The catalog number is T66125 and the CAS number is 192927-63-2.

Moxifloxacin ethyl ester-d5 (Moxifloxacin impurity H-d5) is the deuterium-labeled version of Moxifloxacin ethyl ester.

Moxifloxacin N-sulfate disodium is an anionic sulfonate derivative of Moxifloxacin. Moxifloxacin is an 8-methoxyquinolone antibacterial antibiotic, used in studies of acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and infectious pneumonia.

Moxifloxacin N-sulfate is a metabolite of Moxifloxacin.

Moxifloxacin impurity 8 (N-Methyl moxifloxacin hydrochloride) is an impurity of Moxifloxacin.

Moxifloxacin impurity 9 is an impurity of Moxifloxacin.

Moxifloxacin N-sulfate is a metabolite of moxifloxacin . Moxifloxacin is a fluoroquinolone antibiotic. Formulations containing moxifloxacin have been used in the treatment of bacterial infections, including sinusitis, chronic bronchitis, and pneumonia.

Moxifloxacin-13C-D3 is a fourth-generation fluoroquinolone that has been shown to be effective against Gram-positive, Gram-negative, and atypical strains, as well as multi-drug resistant Streptococcus pneumoniae.

Moxifloxacin-13C,D3 hydrochloride is the 13C labeled variant of Moxifloxacin hydrochloride (TMSM-1673). Moxifloxacin is an orally effective 8-methoxyquinolone compound with antibacterial properties, used in the study of acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and infectious pneumonia.

Moxifloxacin-D4 is a deuterated compound of Moxifloxacin. Moxifloxacin has a CAS number of 151096-09-2. Moxifloxacin is a fourth-generation fluoroquinolone that has been shown to be effective against Gram-positive, Gram-negative, and atypical strains, as well as multi-drug resistant Streptococcus pneumoniae.

Moxifloxacin-D4 hydrochloride is a deuterated compound of Moxifloxacin Hydrochloride (TMSM-1673). Moxifloxacin hydrochloride has a CAS number of 186826-86-8. Moxifloxacin is a fourth generation fluoroquinolone with expanded activity against gram-positive bacteria as well as atypical pathogens. Moxifloxacin has been linked to mild ALT elevations during therapy and to rare instances of idiosyncratic acute liver injury with symptoms and jaundice.

Moxifloxacin Hydrochloride (Standard) is the standard substance of Moxifloxacin Hydrochloride, and it is applicable for quantitative analysis, quality control, and related research in biochemical experiments. Moxifloxacin hydrochloride (BAY12-8039 HCl) is a fourth generation fluoroquinolone with expanded activity against gram-positive bacteria as well as atypical pathogens. Moxifloxacin has been linked to mild ALT elevations during therapy and to rare instances of idiosyncratic acute liver injury with symptoms and jaundice.

Moxifloxacin-[D3] Hydrochloride (Standard) is a reference standard of Moxifloxacin-[D3] Hydrochloride intended for quantitative analysis, quality control, and related biochemical research applications.

(Rac)-Moxifloxacin ((Rac)-BAY 12-8039 free base) is an isomer of Moxifloxacin Hydrochloride. Moxifloxacin Hydrochloride (BAY 12-8039) is an orally effective 8-methoxyquinolone antibacterial agent used in studies on acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and infectious pneumonia.

Moxifloxacin impurity 4 (8-Ethoxymoxifloxacin) is an impurity of Moxifloxacin.